InsiderClue
← All stocks

Compass Therapeutics, Inc.

CMPX Net buying
CIK 0001738021 #3229 in the set updated 18 Sep 2026
Bought (120 mo)
$60.60M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$11.56M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$11.56M
7 of 7 sales
Net
+$49.05M
+$49.05M against sales at will

By person

10 insiders · 55 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
GORDON CARL L
Director
$27.93M (10)
$5.68M (1)
+$22.26M
12,714,404
7.06%
$26.83M
+45.2%
ORBIMED ADVISORS LLC entity
Director
$27.93M (10)
$5.68M (1)
+$22.26M
12,714,404
7.06%
$26.83M
+45.2%
Schuetz Thomas J.
CHIEF EXECUTIVE OFFICER
$1.66M (23)
—
+$1.66M
6,603,336
3.67%
$13.93M
+49.1%
Ferneau Philip
Director
$1.57M (2)
—
+$1.57M
400,280
0.2223%
$844.59K
+364.3%
Sunderland Julie
Director
$1.45M (1)
—
+$1.45M
2,502,025
1.39%
$5.28M
+13.1%
Bisker-Leib Vered
CHIEF EXECUTIVE OFFICER
—
$200.69K (5)
−$200.69K
3,124,426
1.73%
$6.59M
+487.7%
Anderman Jonathan
General Counsel
$30.80K (1)
—
+$30.80K
196,000
0.1088%
$413.56K
+19,500%
Lerner Neil
Chief Accounting Officer
$28.40K (1)
—
+$28.40K
397,500
0.2207%
$838.73K
+32.5%
Toledano Miranda Jayne
Director
—
—
—
1,791,549
0.9948%
$3.78M
—
Shin Barry
CFO
—
—
—
525,000
0.2915%
$1.11M
—

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
ORBIMED ADVISORS LLC
9 Apr 2025
Director
Sell indirect
3,571,428
$1.59
$5.68M
GORDON CARL L
9 Apr 2025
Director
Sell indirect
3,571,428
$1.59
$5.68M
Bisker-Leib Vered
25 Nov 2022
Chief Operating Officer
Sell
2
$4.36
$8.72
Bisker-Leib Vered
23 Nov 2022
Chief Operating Officer
Sell
9,569
$4.30
$41.15K
Bisker-Leib Vered
22 Nov 2022
Chief Operating Officer
Sell
14,929
$4.19
$62.55K
Bisker-Leib Vered
21 Nov 2022
Chief Operating Officer
Sell
16,035
$4.34
$69.59K
Bisker-Leib Vered
18 Nov 2022
Chief Operating Officer
Sell
6,226
$4.40
$27.39K
Show all 55 transactions →

What was left out

Form 4 filings counted 112
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 7,739,324
Sales filed before the plan box existed 5
History held since 23 Jun 2020